| |
Summary
Download the one page summary (pdf 84 KB) of our current  press
releases
|
|
|
2012
|
January 12, 2012:
Novalix/Graffinity enters into multi-target, integrated drug discovery collaboration with Teijin Pharma
Download pdf-file (23 KB)
14_Graff_12_Teijin.pdf
|
|
|
2011
|
August 29, 2011:
NovAliX/Graffinity and Galapagos collaborate in Osteoarthritis discovery research program
Download pdf-file (65 KB)
13_Graff_11_Galapagos.pdf
|
|
|
March 30, 2011
Graffinity enters into drug discovery collaboration with Shionogi
Download pdf-file (72 KB)
12_Graff_11 Shionogi.pdf
|
|
|
2010
|
November
16, 2010
Novalix Acquires a majority interest in Graffinity
Download pdf-file (63 KB)
11_Graff_10 NovAliX.pdf
|
|
|
2009
|
October 15, 2009
Graffinity enters into drug discovery research collaboration with
Genentech
Download pdf-file (96 KB)
10_Graff_09
Genentech.pdf |
| |
|
|
January 26, 2009
Graffinity and Elan launch fragment-based drug discovery collaboration
Download pdf-file (76 KB)
09_Graff_09
Elan.pdf |
| |
2008
|
October 28, 2008
Graffinity and AstraZeneca enter into multi-target drug discovery
alliance
Download pdf-file (74 KB)
08_Graff_08
AstraZeneca.pdf |
| |
|
|
October 19, 2008
Graffinity and EMBL awarded € 0.9 million grant from German Government
Download pdf-file (32 KB)
07_Graff_08
EMBL.pdf |
| |
|
|
June 03, 2008
Graffinity and Rigel enter into drug discovery research alliance
Download pdf-file (83 KB)
06_Graff_08
Rigel.pdf |
| |
2007
|
November 29, 2007
Graffinity announces multitarget drug discovery research collaboration
with Pfizer
Download pdf-file (39 KB)
05_Graff_07
Pfizer.pdf |
| |
|
|
February 26, 2007
Graffinity and Amgen enter into drug discovery research agreement
Download pdf-file (39 KB)
04_Graff_07
Amgen.pdf |
| |
2006
|
December 13, 2006
Boehringer Ingelheim expands drug discovery alliance with Graffinity
Download pdf-file (39 KB)
03_Graff_06
BI.pdf |
| |
|
|
September 07, 2006
Graffinity and Boehringer Ingelheim Pharmaceuticals enter into Drug
Discovery Research Agreement
Download pdf-file (40 KB)
02_Graff_06
BI.pdf |
| |
|
|
January 23, 2006
Graffinity and Mutabilis announce second research collaboration
Technology
Download pdf-file (52 KB)
01_Graff_06
Mutabilis.pdf |
| |
|
|
January 03, 2006
Santhera Announces Management Buy-Out of the Graffinity Drug Discovery
Technology Business
Read pdf-file here (68 KB)
http://santhera.glutrot.de/downloads/PR
Santhera Graffinity MBO.pdf
|
| |
2005
|
October 12, 2005
Cellzome and Santhera´s business unit, Graffinity, awarded - € 2.2
million grant from German Government
Download pdf-file (92 KB)
pr_cz_gra_en_10_2005.pdf
|
| |
|
|
February 24, 2005
Santhera reaches milestone in Serono Drug Discovery collaboration
Download pdf-file (104 KB)
serono_feb_24_2005.pdf
|
|
 |
|
|
|
| |
 |
|
Graffinity Pharmaceuticals GmbH
Im Neuenheimer Feld 518
69120 Heidelberg, Germany
Phone: +49 (0)6221 651 00
Fax: +49 (0)6221 651 01 11
E-Mail: 
Web: www.graffinity.com |
|
|
|
|
|
|
